- Home
- CRTO vs EVMN Comparison
CRTO vs EVMN Comparison
Compare CRTO & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRTO | EVMN |
|---|---|---|
| Founded | 2005 | 2020 |
| Country | France | United States |
| Employees | N/A | 48 |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 806.9M | 825.5M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRTO | EVMN |
|---|---|---|
| Price | $18.30 | $22.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | $34.00 | ★ $43.88 |
| AVG Volume (30 Days) | 367.1K | ★ 381.8K |
| Earning Date | 05-06-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.95 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $2,296,692,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.54 | N/A |
| P/E Ratio | $122.23 | ★ N/A |
| Revenue Growth | ★ 27.65 | N/A |
| 52 Week Low | $15.58 | $13.89 |
| 52 Week High | $27.32 | $33.20 |
Technical Indicators
Market Signals| Indicator | CRTO | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 56.18 | 46.84 |
| Support Level | $18.04 | $21.32 |
| Resistance Level | $19.98 | $23.08 |
| Average True Range (ATR) | 0.60 | 1.25 |
| MACD | 0.23 | 0.13 |
| Stochastic Oscillator | 82.82 | 51.43 |
Price Performance
Historical ComparisonAbout CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.